Հնդկաստան - անգլերեն - Central Drugs Standard Control Organization

obsurge - beclomethasone diprop.,neomycin sulph.,clotrimazole - oint - 0.025,0.5,1;% - 10g

Հնդկաստան - անգլերեն - Central Drugs Standard Control Organization

obsurge - beclomethasone diprop.,neomycin sulph.,clotrimazole - oint - 0.025,0.5,1;%w/w - 10g

Հնդկաստան - անգլերեն - Central Drugs Standard Control Organization

mankind - beclomethasone diprop.,neomycin sulph.,clotrimazole - crm - 0.025,0.5,1;%;/w/w - 10g

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 40 ug

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

stat rx usa llc - beclomethasone dipropionate monohydrate (unii: 4h7l9ai22i) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate monohydrate 42 ug - beconase aq nasal spray is indicated for the relief of the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis. results from 2 clinical trials have shown that significant symptomatic relief was obtained within 3 days. however, symptomatic relief may not occur in some patients for as long as 2 weeks. beconase aq nasal spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement. beconase aq nasal spray should not be used in the presence of untreated localized infection involving the nasal mucosa. beconase aq nasal spray is also indicated for the prevention of recurrence of nasal polyps following surgical removal. clinical studies have shown that treatment of the symptoms associated with nasal polyps may have to be continued for several weeks or more before a therapeutic result can be fully assessed. recurrence of symptoms due to polyps can occur after stopping treatment, depending on the severity of the disease. hypersensitivity to an

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

glaxosmithkline llc - beclomethasone dipropionate monohydrate (unii: 4h7l9ai22i) (beclomethasone - unii:kgz1slc28z) - beclomethasone dipropionate 42 ug - beconase aq nasal spray is indicated for the relief of the symptoms of seasonal or perennial allergic and nonallergic (vasomotor) rhinitis. results from 2 clinical trials have shown that significant symptomatic relief was obtained within 3 days. however, symptomatic relief may not occur in some patients for as long as 2 weeks. beconase aq nasal spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement. beconase aq nasal spray should not be used in the presence of untreated localized infection involving the nasal mucosa. beconase aq nasal spray is also indicated for the prevention of recurrence of nasal polyps following surgical removal. clinical studies have shown that treatment of the symptoms associated with nasal polyps may have to be continued for several weeks or more before a therapeutic result can be fully assessed. recurrence of symptoms due to polyps can occur after stopping treatment, depending on the severity of the disease. hypersensitivity to any of the in

Մալայզիա - անգլերեն - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaforte (malaysia) sdn. bhd. - beclomethasone dipropionate anhydrous usp -

Հնդկաստան - անգլերեն - Central Drugs Standard Control Organization

mac - beclomethasone diprop.,polymyxin b,neomycin sulph.,gramicidin - crm - 0.25mg,5000iu,5mg,0.25mg;/g - 5g/10g

Հնդկաստան - անգլերեն - Central Drugs Standard Control Organization

med manor - beclomethasone diprop.,ketoconazole,neomycin sulph. - crm - 0.025,2.00,0.5;%w/w - 5 g

Կանադա - անգլերեն - Health Canada

pharmaco canada inc. - beclomethasone dipropionate - metered-dose aerosol - 50mcg - beclomethasone dipropionate 50mcg - adrenals